Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Assets Average (2021 - 2025)

Maravai Lifesciences Holdings has reported Assets Average over the past 5 years, most recently at $809.9 million for Q4 2025.

  • Quarterly results put Assets Average at $809.9 million for Q4 2025, down 29.16% from a year ago — trailing twelve months through Dec 2025 was $809.9 million (down 29.16% YoY), and the annual figure for FY2025 was $889.4 million, down 28.72%.
  • Assets Average for Q4 2025 was $809.9 million at Maravai Lifesciences Holdings, down from $873.1 million in the prior quarter.
  • Over the last five years, Assets Average for MRVI hit a ceiling of $2.3 billion in Q1 2023 and a floor of $809.9 million in Q4 2025.
  • Median Assets Average over the past 5 years was $1.6 billion (2021), compared with a mean of $1.6 billion.
  • Biggest five-year swings in Assets Average: soared 51.06% in 2022 and later plummeted 39.94% in 2024.
  • Maravai Lifesciences Holdings' Assets Average stood at $1.9 billion in 2021, then increased by 18.84% to $2.3 billion in 2022, then dropped by 17.13% to $1.9 billion in 2023, then tumbled by 39.11% to $1.1 billion in 2024, then decreased by 29.16% to $809.9 million in 2025.
  • The last three reported values for Assets Average were $809.9 million (Q4 2025), $873.1 million (Q3 2025), and $928.4 million (Q2 2025) per Business Quant data.